What is clinical research?
Clinical research is how new ways to prevent, diagnose, and treat kidney disease are studied and proven. A clinical trial is one kind of clinical research — a carefully designed study that tests a new treatment, such as a medicine, procedure, or device, to learn whether it’s safe and how well it works in people.
Nearly every treatment your kidney team uses today — from blood-pressure medicines to the newest advanced therapies that slow kidney disease — was first proven through clinical research. It’s the bridge between a promising idea in the laboratory and a treatment that helps real patients.
Clinical research is the bridge between a promising idea and a treatment that helps real patients — and it’s how the next generation of kidney care is being built.
Why it matters in kidney care
Kidney care has changed dramatically in just the last few years, and research is the reason. New medicines that protect both the kidneys and the heart exist today only because patients took part in studies that proved they work.
For people living with chronic kidney disease and related conditions, that progress is deeply personal. Every study that succeeds can mean more years of healthy kidney function, better ways to manage symptoms, and — for some — a real chance to delay or avoid dialysis. Research is how the field keeps moving forward, and how a practice stays at the leading edge of what’s possible.
Is clinical research safe?
It’s a natural first question, and the honest answer is that participant safety is built into how clinical research works in the United States.
- FDA regulation. Clinical studies are regulated by the U.S. Food & Drug Administration, and a new treatment must clear safety review before it can be studied in people.
- Independent oversight. Each study is reviewed, approved, and watched over by an independent panel — an Institutional Review Board (IRB) — made up of doctors, researchers, and community members whose job is to protect participants.
- Risks weighed against benefits. That board’s role is to make sure the possible benefits of a study are reasonable compared with its risks before anyone takes part.
- Ongoing monitoring. Participants are watched closely throughout a study, and there are rules in place to act quickly if a concern comes up.
No research can promise to be entirely without risk — that’s true of any treatment, studied or established. What clinical research offers is a tightly structured process designed to keep risks reasonable, to explain them to you clearly before you decide, and to protect you at every step.
What are the benefits of taking part?
People take part in clinical research for different reasons, and the benefits can be both personal and broader.
Earlier access
For some patients, a study can mean access to a promising new treatment before it’s widely available to the public.
A more active role
Many people value being a more active partner in their own care — and often learn more about their condition along the way.
Helping others
Every participant helps move kidney care forward, contributing to treatments that may help future patients living with kidney disease.
It’s worth being clear-eyed, too: a study tests a treatment precisely because its full effects aren’t yet known, so there’s no guarantee any individual will benefit. That’s why the decision is a personal one, made with full information — and why it’s never made under pressure.
Wondering whether research could be part of your kidney care?
Request an AppointmentHow participation typically works
The specifics vary from study to study, but clinical research generally follows a few familiar steps. (The studies currently available at Georgia Nephrology, who qualifies, and how to join are details we’re finalizing with our physicians.)
- Seeing if it’s a fit. Each study has eligibility criteria — things like your specific kidney condition, your overall health, and other treatments you take. A screening visit, which may include a review of your history and some tests, helps determine whether a study is appropriate for you.
- Informed consent. Before anything begins, the study is fully explained — what it’s testing, what you’d be asked to do, the possible risks and benefits, and your rights. You can ask as many questions as you need before deciding.
- Taking part. If you choose to join, you’d follow the study’s plan, often with regular visits and monitoring to keep you safe and track how things are going.
- Your regular care continues. Research is meant to work alongside your ongoing kidney care — not replace your relationship with your nephrologist.
Voluntary, always
This is the part worth saying plainly: taking part in research is entirely your choice, and you can change your mind at any time.
The informed consent you sign isn’t a contract that binds you — it’s a document designed to protect you and make sure your decision is truly informed. You have the right to leave a study at any point, for any reason, without it affecting the regular medical care your kidney team provides. If you do decide to stop, it’s best to let the research team know so they can look after your safety as you do.
Participation is always voluntary, with informed consent and safety oversight — and you can leave at any time, for any reason.
Research at Georgia Nephrology
Through the Georgia Nephrology Research Institute, clinical studies are part of how we stay at the leading edge of kidney care — and for some patients, they can mean access to promising treatments before they’re widely available. It reflects a practice that has cared for metro Atlanta’s kidneys since 1976 and stays current with a fast-moving field.
Detailed information for this page is being finalized with our physicians — including the studies currently available, who may qualify, and how to learn more. In the meantime, your nephrologist is the best person to talk with about whether research might fit your care, and you’re always welcome to contact us or meet our providers to start a conversation.
